Immune-related Adverse Events Associated With Checkpoint Inhibition in the Setting of CAR T Cell Therapy: A Case SeriesSwetha Kambhampati, Charalambos Andreadis, Lissa Gray et al.|Clinical Lymphoma Myeloma & Leukemia|2019Cited by 24
Higher cardiorespiratory fitness predicts long-term survival in patients with heart failure and preserved ejection fraction: the Henry Ford Exercise Testing (FIT) ProjectOlusola A. Orimoloye, Michael J. Blaha, Swetha Kambhampati et al.|Archives of Medical Science|2019Cited by 21
Infectious Complications of BCMA-Targeted and CD19-Targeted Chimeric Antigen Receptor T-Cell ImmunotherapySwetha Kambhampati, Sandy W. Wong, Bita Fakhri et al.|Blood|2020Cited by 12
Carfilzomib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma: A Phase I TrialSwetha Kambhampati, Charalambos Andreadis, Bita Fakhri et al.|Clinical Lymphoma Myeloma & Leukemia|2020Cited by 8
Ofatumumab, Etoposide, and Cytarabine Intensive Mobilization Regimen in Patients with High-risk Relapsed/Refractory Diffuse Large B-Cell Lymphoma Undergoing Autologous Stem Cell TransplantationSwetha Kambhampati, Charalambos Andreadis, Bradley D. Hunter et al.|Clinical Lymphoma Myeloma & Leukemia|2020Cited by 3